4th Clinical Consensus Symposium Neuroplasticity in Action – From Research to Clinical Practice: Understanding and Translating Neurobiological Foundations of Neurologic Music Therapy® (NMT™)

Event Notes:

We invite you to join us for the 4th Clinical Consensus Symposium: Neuroplasticity in Action. This Symposium will connect relevant cutting-edge research to clinical practice, with a focus on the neurobiological foundations of Neurologic Music Therapy® (NMT™).

Through expert presentations, participants will explore the fundamental mechanisms underlying applied music neuroscience to optimize the clinical impact of the Transformation Design Model (TDM)™ and the NMT™ System of Techniques. Presentations will include,

• Key Underlying Neurobiological Foundations of Neurologic Music Therapy® (NMT)™ with Dr. Michael Thaut, Ph.D.
• Assessment and Outcome Measures with Dr. Stefan Mainka (NMT-F,Germany), Hannah Rhineheart (NMT-F, USA), and Joe Thompson (NMT-F, Australia)
• Why Mechanisms Matter with D’Mico May, Jacob Lingenbrink, and Kade Brandhagen – Recipients of NMT™ through Neurologic Music Therapy® Services of Arizona
• Rhythmic Entrainment with Dr. Michael Thaut Ph.D.
• Augmented Auditory Feedback and Sonification with Dr. Nina Schaffert, Dr. Thenille Braun Janzen, and Kathrin Mertel (NMT-F)
• Neuroplasticity/Neuroconnectivity with Dr. Jonathon Burdette, M.D.
• Enhanced Motivation States with Dr. Dana Boering, M.D.
• The role of the TDM™ in creating a Medical Necessity Framework with Brechen Santeramo (NMT-F, Colorado, USA), Dr. Cheryl Jones, Ph.D. (NMT-F, Ontario, Canada), and Elizabeth Nightengale (NMT-F, London, United Kingdom)
• Musical/Non-Musical Parallels vs. Non-Musical Exercise with ​Dr. Corene Thaut, Ph.D.
• Importance of NMT™ in Low-Income Countries with Lauren Kressler (NMTAP, Ecuador)
• Ethics/License FAQs with the Advisory Council

And more! We look forward to seeing you there!

Important Information

• All presentations will be offered live (synchronously) and will also be recorded and posted (asynchronously) to ensure accessibility across time zones. These will be available through the end of April.
• This Symposium is open to affiliates and non-affiliates of the Academy.
• Closed Captioning (with option for translation) provided by Zoom
• All participants are required to either participate in a focused forum during the Symposium OR attend and participate in a Support Chapter Meeting/Focused Forum after the Symposium to receive their certificate and credits
• Presentation schedule is subject to change

Symposium Objectives:

• Participants will identify at least 3 standardized evaluation tools that support clinical decision-making based on specific functional impairments (MT Board Certification Domain II. B. 3,4,5,7,12).
• Participants will write out a description of how they would use the 6 steps of the Transformational Design Model (TDM)(R) to create an appropriate clinical exercise that targets specific functional impairment (III. A. 2, 3, 4, 5).
• Participants will articulate at least 3 examples of current and future directions in telehealth, education, business models, and NMT clinical practice (V.A.2, 7).
• Participants will identify 4 important professional ethical responsibilities related to ethical practices in NMT (V. B. 2).